Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.

about

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.

Item

http://www.wikidata.org/entity/Q48502128

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@en

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@nl

type

Item

label

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@en

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@nl

prefLabel

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@en

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@nl

P1476

Addition of 5-fluorouracil to ...... nced nasopharyngeal carcinoma.

@en

P2093

Fu Zhenfu

http://www.w3.org/2001/XMLSchema#string

Jiang Chuner

http://www.w3.org/2001/XMLSchema#string

Jiang Yangming

http://www.w3.org/2001/XMLSchema#string

Liu Jiping

http://www.w3.org/2001/XMLSchema#string

Liu Tongxin

http://www.w3.org/2001/XMLSchema#string

Masoto Sakamoto

http://www.w3.org/2001/XMLSchema#string

Qin Weifeng

http://www.w3.org/2001/XMLSchema#string

Shi Kaiyuan

http://www.w3.org/2001/XMLSchema#string

Sun Quanquan

http://www.w3.org/2001/XMLSchema#string

Wang Fangzheng

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Significant benefits of adding neoadjuvant chemotherapy before concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of randomized controlled trials.

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.

Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.

How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?

The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.

Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.

Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.

P304

115469-115479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23300

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29383174

http://www.w3.org/2001/XMLSchema#string

P932

5777786

http://www.w3.org/2001/XMLSchema#string